drugset / Trial / NCT00491829
Flibanserin Versus Placebo in Premenopausal Women With HSDD
RandomizedParallel-groupDouble-blindTreatment
Summary
To establish efficacy of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in 6-month treatment, vs placebo for Hypoactive Sexual Desire Disorder in premenopausal European women. To evaluate safety and tolerability of flibanserin in such patients.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | flibanserin | Small molecule | 50 mg | — |
| Subject | flibanserin | Small molecule | 100 mg | — |